LOADING
Comparing Merck & Company (MRK) and Coinbase Global (COIN) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | COIN |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $376.4B | $49.2B |
| P/E Ratio | 122.0 | -- |
| Forward P/E | 55.6 | 833.3 |
| PEG Ratio | 10.47 | 10.58 |
| EPS | $1.25 | $-3.88 |
| Revenue Growth (YoY) | 5.1% | -17.3% |
| Profit Margin | 4.8% | -16.3% |
| Return on Equity | 7.0% | -7.8% |
| Dividend Yield | 2.23% | -- |
| Beta | 0.21 | 3.36 |
| 52-Week High | $154.49 | $402.16 |
| 52-Week Low | $75.81 | $139.11 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.